Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Insulin Market 2016 Analysis and Forecast 2020

Thursday, September 22, 2016 6:13
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Beta cells of the pancreas produce insulin, a hormone that regulates blood glucose levels, by stimulating cells to absorb glucose from the blood. In the cells, glucose is converted into energy, which is used by tissues and muscles to perform their physiological functions. This process is restricted in people with diabetes, resulting in the accumulation of glucose in the blood. This condition is known as hyperglycemia; it damages body tissues over a period, leading to life-threatening health complications such as diabetic retinopathy and diabetic nephropathy. In type 1 diabetes or gestational diabetes, the immune system attacks the pancreatic cells, resulting in little or no insulin production. In type 2 diabetes, the body does not produce sufficient insulin to regulate blood glucose levels. In both type 1 and type 2 diabetes, the individual requires daily doses of insulin along with other medications, depending on the condition. Different types of insulin products, such as human insulin and insulin analogs, are available for insulin replacement therapy. 

For more information about this report: .

Publisher’s analysts forecast the insulin market in the US and Europe to grow at a CAGR of 6.17% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the insulin market in the US and Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.

The market is divided into the following segments based on geography: 
- US
- Europe

Publisher’s report, Insulin Market in the US and Europe 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 


Make an enquiry: .


Key vendors 
- Sanofi
- Novo Nordisk
- Eli Lilly
Other prominent vendors 
- Adocia
- Biocon
- Biodel
- Biogenomics
- Boehringer Ingelheim
- Dance Biopharm
- Diasome Pharmaceuticals
- Exsulin
- Generex
- Lexicon Pharmaceuticals
- Ligand Pharmaceuticals
- MannKind
- Macrogenics
- Merck
- Melior Pharmaceuticals
- Metabolic Solutions Development Company
- NGM Biopharmaceuticals
- NuSirt Biopharma
- Oramed Pharmceuticals
- PhaseBio Pharmaceuticals
- Pfizer
- Thermalin Diabetes
- Tolerion
- VeroScience
- vTv Therapeutics
- Wockhardt

Market driver 
- Advances in insulin delivery technology 
- For a full, detailed list, view our report 

Market challenge 
- Complexity of insulin production
- For a full, detailed list, view our report 

Market trend 
- Increasing price of insulin drugs
- For a full, detailed list, view our report 


Buy this Report: .

Contact Us:
Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.